On the road with Milly: LRG Advocates in Washington, DC
Live from Washington By Mildred Menos Hi Guys, Some of you may know me from hosting GDOLs (GIST Days of Learning in your city, that welcome phone call you received when you became a [...]
Live from Washington By Mildred Menos Hi Guys, Some of you may know me from hosting GDOLs (GIST Days of Learning in your city, that welcome phone call you received when you became a [...]
In Santiago, Chile, on April 22, 2015, The Chilean Health Ministry (MINSAL) organized a seminar to discuss regional policies for cancer prevention and control. Representatives of WHO, OPS, RINC, and UNASUR, were invited along [...]
The Life Raft Group is pleased to announce its recent membership in One Voice Against Cancer (OVAC). Established in 2000, OVAC has grown to become the Capitol’s leading cancer coalition by unifying US cancer [...]
New steps have been taken in Chile that will benefit patients who need high cost treatments. Piga Fernández, LRG Global Consultant in Chile, together with representatives of 26 patient organizations has been working on [...]
A recent article in Forbes reports that although we are witnessing a time of historic breakthroughs in cancer treatments, we are lagging behind on policy breakthroughs in the development, funding and delivery of excellent cancer [...]
Our GIST Wishes We highlighted one GIST wish every day in the month of December, turning our hopes and dreams into visions for the future. Members and staff shared their heartfelt wishes such as: [...]
The Life Raft Group joins the global community in honoring World Cancer Day 2015.We join with everyone in the cancer community: researchers, physicians, advocates, patient organizations, government agencies, and most importantly, patient and caregivers to [...]
Advocacy for GIST patients is a vital part of the work the Life Raft Group undertakes, but there are advocacy “superheroes” out there, going above and beyond to ensure that all GIST patients receive [...]
The sixth annual Partnering for Cures meeting sponsored by FasterCures was held November 16-18 in New York City. Over 1,000 attendees from biopharma, governmental agencies, academia, philanthropy and patient advocacy organizations came together to [...]
The National Health Service (NHS) in the United Kingdom has announced plans to halt funding through the Cancer Drug Fund for regorafenib (Stivarga), thereby preventing GIST patients from having access to this life-saving medication.We at [...]